These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12870569)

  • 1. Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia.
    Emsley RA; Buckley P; Jones AM; Greenwood MR
    J Psychopharmacol; 2003 Jun; 17(2):210-5. PubMed ID: 12870569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
    Emsley RA; Raniwalla J; Bailey PJ; Jones AM
    Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
    Copolov DL; Link CG; Kowalcyk B
    Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
    Purdon SE; Malla A; Labelle A; Lit W
    J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
    Chengappa KN; Goldstein JM; Greenwood M; John V; Levine J
    Clin Ther; 2003 Feb; 25(2):530-41. PubMed ID: 12749512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
    Buckley PF; Goldstein JM; Emsley RA
    Schizophr Res; 2004 Feb; 66(2-3):143-50. PubMed ID: 15061246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine has a direct effect on the negative symptoms of schizophrenia.
    Tandon R
    Hum Psychopharmacol; 2004 Dec; 19(8):559-63. PubMed ID: 15486960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.
    Nakajima S; Takeuchi H; Fervaha G; Plitman E; Chung JK; Caravaggio F; Iwata Y; Mihashi Y; Gerretsen P; Remington G; Mulsant B; Graff-Guerrero A
    Schizophr Res; 2015 Feb; 161(2-3):429-33. PubMed ID: 25556080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine. A review of its use in the management of schizophrenia.
    Cheer SM; Wagstaff AJ
    CNS Drugs; 2004; 18(3):173-99. PubMed ID: 14871161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
    El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of acute response with quetiapine in psychotic mood disorders.
    Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J
    J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cognitive function improve with quetiapine in comparison to haloperidol?
    Velligan DI; Newcomer J; Pultz J; Csernansky J; Hoff AL; Mahurin R; Miller AL
    Schizophr Res; 2002 Jan; 53(3):239-48. PubMed ID: 11738537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine--efficacy in different domains.
    Sharma T
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S385-90. PubMed ID: 11587885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia.
    Kasper S
    Depress Anxiety; 2004; 20(1):44-7. PubMed ID: 15368596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.